Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), today announced its largest portfolio expansion in Australia ...
EDMONTON, AB, June 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the ...
Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and ...
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the ...
ScienceAlert on MSN
Large Medical Cannabis Review Finds Scarce Evidence It Treats Mental Health Disorders
(Anastassiya Bezhekeneva/Getty Images) A large umbrella review has found no strong evidence to date that medicinal cannabis ...
By Sriparna Roy March 16 (Reuters) - Cannabis-based medicines have shown little evidence of effectiveness for treating most ...
There’s “no evidence” that medical marijuana is effective in treating anxiety, depression or post-traumatic stress, according ...
EDMONTON, AB, Feb. 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended ...
The Legalise Cannabis South Australia Party has unveiled what it says a regulated cannabis dispensary could look like if the ...
Chief Financial Officer Simona King outlined the company’s recent strategic pivot toward medical cannabis and international expansion during a fireside chat at the TD Cowen Healthcare Conference, ...
A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results